Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

A woman with Cushing's syndrome improved after surgery to remove an adrenal tumor.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Measuring cortisol in hair can help assess adrenal function in asthmatic children using inhaled corticosteroids.

Hirsutism in Afghan women varies by community, influenced by awareness, education, and socio-economic status.

Hair cortisol measurement is a promising, non-invasive tool for monitoring cortisol exposure over time.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Local estrogen synthesis in skin may improve wound healing.

Isotretinoin treatment in teens with acne can cause hormonal changes, leading to menstrual irregularity and increased hirsutism.

Trilostane generally improved symptoms in dogs with Cushing's syndrome, but dosage adjustments were needed over time.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Adult-onset hair loss in Chesapeake Bay retrievers may be linked to abnormal adrenal hormone production.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Hair growth issues can be linked to genetics, diseases, or medications, and new treatments are being developed.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.